Table 2:

Multivariable survival analysis performed on the test sets (D₂, D₃, and D₄) including SpaTIL.

Variable	Hazard Ratio (95% Confidence Interval)	p-value
Gender Male vs. Female	1.18 (0.85–1.65)	0.32
T-stage T1 vs. T2	0.98 (0.68–1.40)	0.90
N-stage N0 vs. N1	0.91 (0.59–1.41)	0.68
Stage Stage I vs. Stage II	1.01 (0.65–1.58)	0.96
Tumor subtypes ADCs vs. SCC vs. others	0.92 (0.72–1.19)	0.53
SpaTIL recurrence vs. non-recurrence	3.08 (2.10–4.51)	7.3×10−5
Two-sided p < 0.05 (in bold) was considered as statistically significant.